Eris Lifesciences quarter results:FY21 Revenues at INR 12,119 mn up 12.8% YoY EBITDA at INR 4,306 mn
Eris Lifesciences quarter results: FY21 Revenues at INR 12,119 mn, up 12.8% YoY EBITDA at INR 4,306 mn. Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, today announced … Read More









